This inventor holds 3 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Glaxo Group Limited. Active years: 2014-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014-2020
Title: Maria Feeney: Innovator in Antigen Binding Proteins
Introduction
Maria Feeney is a prominent inventor based in Stevenage, GB. She has made significant contributions to the field of biotechnology, particularly in the development of antigen binding proteins. With a total of 3 patents to her name, her work has the potential to impact medical treatments and pharmaceutical compositions.
Latest Patents
Maria's latest patents focus on antigen binding proteins that specifically bind to Oncostatin M (OSM). These inventions are particularly relevant for human OSM (hOSM) and aim to inhibit the binding of OSM to the gp130 receptor without directly interacting with site II residues. Additionally, her patents disclose methods for humanizing antibodies, along with pharmaceutical compositions, screening, and medical treatment methods.
Career Highlights
Maria Feeney is associated with Glaxo Group Limited, where she continues to innovate and contribute to the field of biotechnology. Her work is characterized by a commitment to advancing medical science through her inventions.
Collaborations
Throughout her career, Maria has collaborated with notable colleagues, including Gary Peter Bembridge and Chun-wa Chung. These partnerships have further enriched her research and development efforts.
Conclusion
Maria Feeney stands out as a dedicated inventor whose work in antigen binding proteins holds promise for future medical advancements. Her contributions to biotechnology are noteworthy and reflect her commitment to innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile